BACKGROUND: The selection of patients with renal artery stenosis (RAS) likely to improve glomerular filtration rate (GFR) after percutaneous transluminal renal angioplasty is difficult. We examined basal hemodynamic and inflammatory factors linked to improved stenotic kidney (STK) function after percutaneous transluminal renal angioplasty in swine RAS. METHODS AND RESULTS: Fifteen pigs after 6 weeks of hemodynamically significant RAS were studied before and 4 weeks after technically successful percutaneous transluminal renal angioplasty+stenting. STK and contralateral kidney hemodynamics and function were evaluated by multidetector computed-tomography before and after acetylcholine challenge. Single-kidney deoxyhemoglobin (R2*, reciprocal to blood relaxation) and energy-dependent tubular function were assessed using blood-oxygen-level-dependent magnetic resonance imaging before and after furosemide. Baseline renal vein and inferior vena cava levels of inflammatory markers were measured and their gradient and net release calculated. Baseline parameters were compared with normal (n=7) and sham-RAS (n=7) pigs and correlated with the change in STK-GFR after revascularization (ΔGFR). Four weeks after percutaneous transluminal, renal angioplasty blood pressure was normalized in all animals, but STK-GFR improved in 10 of 15 (ΔGFR =+22.0±8.5 mL/min). ΔGFR correlated inversely with basal STK-GFR, renal release of inflammatory markers, and medullary R2* response to furosemide, but directly with GFR response to acetylcholine. Basal contralateral kidney GFR correlated directly with ΔGFR. CONCLUSIONS: Low basal STK-GFR with preserved response to acetylcholine may predict benefit from revascularization in RAS, whereas renal inflammation and robust STK-R2* responses to furosemide (possibly reflecting avid tubular oxygen consumption) are associated with less favorable outcomes. These tools may be useful for identification of patients likely to improve renal function after revascularization.
BACKGROUND: The selection of patients with renal artery stenosis (RAS) likely to improve glomerular filtration rate (GFR) after percutaneous transluminal renal angioplasty is difficult. We examined basal hemodynamic and inflammatory factors linked to improved stenotic kidney (STK) function after percutaneous transluminal renal angioplasty in swine RAS. METHODS AND RESULTS: Fifteen pigs after 6 weeks of hemodynamically significant RAS were studied before and 4 weeks after technically successful percutaneous transluminal renal angioplasty+stenting. STK and contralateral kidney hemodynamics and function were evaluated by multidetector computed-tomography before and after acetylcholine challenge. Single-kidney deoxyhemoglobin (R2*, reciprocal to blood relaxation) and energy-dependent tubular function were assessed using blood-oxygen-level-dependent magnetic resonance imaging before and after furosemide. Baseline renal vein and inferior vena cava levels of inflammatory markers were measured and their gradient and net release calculated. Baseline parameters were compared with normal (n=7) and sham-RAS (n=7) pigs and correlated with the change in STK-GFR after revascularization (ΔGFR). Four weeks after percutaneous transluminal, renal angioplasty blood pressure was normalized in all animals, but STK-GFR improved in 10 of 15 (ΔGFR =+22.0±8.5 mL/min). ΔGFR correlated inversely with basal STK-GFR, renal release of inflammatory markers, and medullary R2* response to furosemide, but directly with GFR response to acetylcholine. Basal contralateral kidney GFR correlated directly with ΔGFR. CONCLUSIONS: Low basal STK-GFR with preserved response to acetylcholine may predict benefit from revascularization in RAS, whereas renal inflammation and robust STK-R2* responses to furosemide (possibly reflecting avid tubular oxygen consumption) are associated with less favorable outcomes. These tools may be useful for identification of patients likely to improve renal function after revascularization.
Authors: Irfan I Galaria; Scott M Surowiec; Jeffrey M Rhodes; Karl A Illig; Cynthia K Shortell; Yaron Sternbach; Richard M Green; Mark G Davies Journal: Ann Vasc Surg Date: 2005-03 Impact factor: 1.466
Authors: P N Harden; M J MacLeod; R S Rodger; G M Baxter; J M Connell; A F Dominiczak; B J Junor; J D Briggs; J G Moss Journal: Lancet Date: 1997-04-19 Impact factor: 79.321
Authors: J Webster; F Marshall; M Abdalla; A Dominiczak; R Edwards; C G Isles; H Loose; J Main; P Padfield; I T Russell; B Walker; M Watson; R Wilkinson Journal: J Hum Hypertens Date: 1998-05 Impact factor: 3.012
Authors: A Eirin; S M Herrmann; A Saad; A Abumoawad; H Tang; A Lerman; S C Textor; L O Lerman Journal: Acta Physiol (Oxf) Date: 2019-03-13 Impact factor: 6.311
Authors: Alfonso Eirin; Xiang-Yang Zhu; Zilun Li; Behzad Ebrahimi; Xin Zhang; Hui Tang; Michael J Korsmo; Alejandro R Chade; Joseph P Grande; Christopher J Ward; Robert D Simari; Amir Lerman; Stephen C Textor; Lilach O Lerman Journal: Arterioscler Thromb Vasc Biol Date: 2013-02-21 Impact factor: 8.311
Authors: Arash Aghajani Nargesi; Lihong Zhang; Hui Tang; Kyra L Jordan; Ishran M Saadiq; Stephen C Textor; Lilach O Lerman; Alfonso Eirin Journal: J Hypertens Date: 2019-10 Impact factor: 4.844
Authors: Alfonso Eirin; Barbara J Williams; Behzad Ebrahimi; Xin Zhang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman Journal: J Hypertens Date: 2014-01 Impact factor: 4.844
Authors: Alfonso Eirin; Xin Zhang; Xiang-Yang Zhu; Hui Tang; Kyra L Jordan; Joseph P Grande; Allan B Dietz; Amir Lerman; Stephen C Textor; Lilach O Lerman Journal: Nephrol Dial Transplant Date: 2013-10-03 Impact factor: 5.992
Authors: Rahele A Farahani; Xiang-Yang Zhu; Hui Tang; Kyra L Jordan; Lilach O Lerman; Alfonso Eirin Journal: Am J Physiol Renal Physiol Date: 2020-05-28
Authors: Weijian Shao; Kayoko Miyata; Akemi Katsurada; Ryousuke Satou; Dale M Seth; Carla B Rosales; Minolfa C Prieto; Kenneth D Mitchell; L Gabriel Navar Journal: Am J Physiol Renal Physiol Date: 2016-05-18